AbbVie (NYSE:ABBV) Stock Quotes, Forecast and News Summary

Q: What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

AbbVie Stock (NYSE: ABBV) stock price, news, charts, stock research, profile.

Open	$193.95
Close	$192.87
Volume / Avg.	3.98M / 6.26M
Day Range	$192.78 - $195.18
52 Wk Range	153.58 - 207.32
Market Cap	$340.83B
P/E Ratio	80.94
Dividend Yield	3.39%
Exchange	NYSE
RSI	68
Short Interest	1.07%
Days to Cover	2.73

Recent News

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?

AbbVie and Xilio partner to develop tumor-activated immunotherapies. Xilio's pipeline includes masked T cell engagers for prostate, gastric, and lung cancers.

Vandana Singh

These Stocks Missed on Earnings, But Will Rebound Next Quarter

Earnings season is when investors get a progress report about the companies in their portfolio or on their watchlist. An earnings report is generally a lagging indicator. That’s because the headline numbers tell

MarketBeat

Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.” He added, “I can't believe the stock dropped so much.”

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$193.95
Close	$192.87
Volume / Avg.	3.98M / 6.26M
Day Range	$192.78 - $195.18
52 Wk Range	153.58 - 207.32
Market Cap	$340.83B
P/E Ratio	80.94
Dividend Yield	3.39%
Exchange	NYSE
RSI	68
Short Interest	1.07%
Days to Cover	2.73

About Abbvie Inc

Sector

Health Care

Industry

Biotechnology

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinv...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy AbbVie (ABBV) stock?

You can purchase shares of AbbVie (NYSE:ABBV) through any online brokerage.

View our list of the best stock brokerages

Who are AbbVie (ABBV) competitors?

Other companies in AbbVie’s space includes: BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for AbbVie (ABBV) stock?

AbbVie has a consensus price target of $193.65.

What is the current price for AbbVie (ABBV)?

The stock price for AbbVie (NYSE: ABBV) is $192.87 last updated February 14, 2025 at 6:22 PM EST.

Does AbbVie (ABBV) pay a dividend?

A quarterly cash dividend of 1.64 per share of Class A Common Stock. The quarterly cash dividend was payable on February 14, 2025 to stockholders of record on January 15, 2025.

When is AbbVie (NYSE:ABBV) reporting earnings?

AbbVie’s Q1 earnings are confirmed for Friday, April 25, 2025.

Is AbbVie (ABBV) going to split?

There is no upcoming split for AbbVie.

What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Comments

AbbVie

AbbVie (ABBV) Forecast